Abstract:20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol (I) has been isolated as a metabolite of ginseng saponins by Paecilomyces bainier. The crystal structure of (I) was also investigated by single crystal X-ray diffraction analysis. It crystallizes in the monoclinic space group P21, with a = 15.99 2 (3) Å, b = 11.960 (19) Å, c = 20.127 (3) Å, β = 101.85 (4)°, and V = 3767.5 (11) Å3, Z = 4, R int = 0.1129, ωR(F 2) = 0.1749, F(000) = 1,448. The title compound is a dammarane-type triterpenoid, and the four rings of this compound connect with each other in trans characteristics,with the three-six-membered rings in chair conformation and the five-membered ring adopting envelope one. A β-d-glucopyranosyl group and a 2-methyl-2-pentenyl group connect to C20 of S configuration. The space symmetrical motif is adopted and each packing unit-cell contains two symmetrical compound (I) molecules and four H2O molecules. The hydrogen-bonding (both intra- and inter-molecular) interactions play a major role in this structural association.

20-O-β-d-xylopyranos-yl(1→6)-β-d-glucopyranosyl-20(s)-protopanaxadiol Methanol Solvate.

4-Des-oxy-4β-[(5-meth-oxy-1H-indol-3-yl)oxalylamino]podophyllotoxin methanol solvate.

2-Acetyl-amino-1,3,4,6-tetra-O-(tri-methyl-silyl)-2-de-oxy-α-d-gluco-pyran-ose.

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Methyl 3Β-Methoxy-carbon-yloxy-4,4-di-methyl-17-oxo-16α-(3-oxobut-yl)-16β-carboxylate.

Methyl 3&#946;-methoxycarbonyloxy-4,4-dimethyl-17-oxo-16&#945;-(3-oxobutyl)-16&#946;-carboxylate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

X-ray Structure Investigation of 20-O-β-d-glucopyranosyl-20(s)-protopanaxadiol

3Β,12β,14α-Trihydroxypregnan-20-one

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

1-Ethyl-2-oxo-5-phenyl-1,6-dihydro-2h-oxazolo[4′,5′:5,6]Pyrido[3,4-b]indole Methanol Hemisolvate

3 ',6 '-Bis(Ethylamino)-2 ',7 '-Dimethyl-2-{2-(E)-[(Thiophen-2-Yl)Methylideneamino]Ethyl}Spiro[Isoindo Line-1,9 '-Xanthen]-3-One Methanol Monosolvate

20-Oxopregna-5,16-dien-3β-yl Acetate

1,3-Dioxo-2,3-dihydro-1h-isoindol-2-yl 2,3,4-Tri-o-acetyl-β-d-xyloside.

2-Ethyl-8-methoxy-methyl-4-oxo-4h-chromen-7-yl (1S,4r)-4,7,7-trimethyl-3-oxo-2-oxabicyclo-[2.2.1]heptane-1-carboxyl-ate.

Methyl 7-(4-bromophenyl)-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carbo Xylate

3,4-O-isopropylidene-2,7-di-o-p-tolylsulfonyl-α-l-xylo-3-heptulo-3,6-furanosononitrile

3&#8242;,6&#8242;-Bis(ethylamino)-2&#8242;,7&#8242;-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9&#8242;-xanthen]-3-one methanol monosolvate

(4′S)-4′-Ethyl-3′,10′-dioxo-3′,4′, 7′,8′-tetrahydrospiro-[1,3-dioxolane-2,6′-1′H, 6′H-pyrano[3,4-f]indolizin]-4′-yl N-(1-phenylethyl)carbamate